41 related articles for article (PubMed ID: 11830513)
1. Evolution: Back to the future to understand and control prostate cancer.
Coffey DS
Asian J Urol; 2014 Oct; 1(1):4-11. PubMed ID: 29511632
[No Abstract] [Full Text] [Related]
2. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
[TBL] [Abstract][Full Text] [Related]
3. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
4. RNA-Mediated Regulation of HMGA1 Function.
Benecke AG; Eilebrecht S
Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNA let-7 and its major targets in prostate cancer.
Wagner S; Ngezahayo A; Murua Escobar H; Nolte I
Biomed Res Int; 2014; 2014():376326. PubMed ID: 25276782
[TBL] [Abstract][Full Text] [Related]
6. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.
Shi XB; Xue L; Ma AH; Tepper CG; Gandour-Edwards R; Kung HJ; deVere White RW
Oncogene; 2013 Aug; 32(35):4130-8. PubMed ID: 23069658
[TBL] [Abstract][Full Text] [Related]
8. Role of nuclear architecture in epigenetic alterations in cancer.
Easwaran HP; Baylin SB
Cold Spring Harb Symp Quant Biol; 2010; 75():507-15. PubMed ID: 21447817
[TBL] [Abstract][Full Text] [Related]
9. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion.
Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P
Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859
[TBL] [Abstract][Full Text] [Related]
10. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
Albrethsen J; Knol JC; Piersma SR; Pham TV; de Wit M; Mongera S; Carvalho B; Verheul HM; Fijneman RJ; Meijer GA; Jimenez CR
Mol Cell Proteomics; 2010 May; 9(5):988-1005. PubMed ID: 20089989
[TBL] [Abstract][Full Text] [Related]
11. High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
Liau SS; Whang E
Surgeon; 2009 Oct; 7(5):297-306. PubMed ID: 19848064
[TBL] [Abstract][Full Text] [Related]
12. HMGB1: endogenous danger signaling.
Klune JR; Dhupar R; Cardinal J; Billiar TR; Tsung A
Mol Med; 2008; 14(7-8):476-84. PubMed ID: 18431461
[TBL] [Abstract][Full Text] [Related]
13. Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins.
Maloney SC; Adair JE; Smerdon MJ; Reeves R
DNA Repair (Amst); 2007 Sep; 6(9):1371-9. PubMed ID: 17540622
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics of prostate cancer: beyond DNA methylation.
Schulz WA; Hatina J
J Cell Mol Med; 2006; 10(1):100-25. PubMed ID: 16563224
[TBL] [Abstract][Full Text] [Related]
15. Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.
Chang ZG; Yang LY; Wang W; Peng JX; Huang GW; Tao YM; Ding X
Dig Dis Sci; 2005 Oct; 50(10):1764-70. PubMed ID: 16187170
[TBL] [Abstract][Full Text] [Related]
16. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.
Louis SF; Vermolen BJ; Garini Y; Young IT; Guffei A; Lichtensztejn Z; Kuttler F; Chuang TC; Moshir S; Mougey V; Chuang AY; Kerr PD; Fest T; Boukamp P; Mai S
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9613-8. PubMed ID: 15983382
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nuclear matrix proteins between gastric cancer and normal gastric tissue.
Zhang QX; Ding Y; Li Z; Le XP; Zhang W; Sun L; Shi HR
World J Gastroenterol; 2004 Jun; 10(12):1819-21. PubMed ID: 15188514
[TBL] [Abstract][Full Text] [Related]
18. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells.
Takaha N; Hawkins AL; Griffin CA; Isaacs WB; Coffey DS
Cancer Res; 2002 Feb; 62(3):647-51. PubMed ID: 11830513
[TBL] [Abstract][Full Text] [Related]
19. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells.
Takaha N; Resar LM; Vindivich D; Coffey DS
Prostate; 2004 Jul; 60(2):160-7. PubMed ID: 15162382
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
